Medicare Enrolled
Dr. Robert Naismith, MD
Urology Physician · Corpus Christi, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Naismith from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Naismith?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Naismith
Dr. Robert Naismith is an urology physician in Corpus Christi, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Naismith performed 4,446 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Naismith received a total of $4,182 from 28 pharmaceutical and/or device companies across 168 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Naismith is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 27% volume in TX
$4,182 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗4,446
Medicare services
Top 27% in TX for urology physician
Not available
Unique patients (not deduplicated)
$47
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
1,235 | $4 | $25 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
649 | $7 | $31 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
629 | $91 | $370 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
554 | $62 | $257 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 183 | $132 | $750 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
177 | $8 | $15 |
| PSA test (prostate cancer screening) | 172 | $18 | $105 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
170 | $173 | $683 |
| Additional urethral implant in prostate Placement of an additional implant into the urethra within the prostate gland using an endoscope. |
83 | $39 | $508 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
83 | $117 | $483 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
72 | $0 | $30 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
67 | $74 | $323 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
51 | $38 | $163 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
39 | $24 | $98 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
39 | $62 | $232 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
38 | $4 | $31 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
24 | $18 | $125 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
23 | $174 | $686 |
| Urethral implant insertion in prostate A single implant is placed into the urethra within the prostate gland using an endoscope. |
23 | $161 | $1,123 |
| Insertion of temporary bladder tube | 22 | $35 | $129 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
22 | $94 | $348 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
17 | $188 | $701 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
17 | $107 | $583 |
| Laser vaporization of prostate A procedure that uses a laser to remove excess prostate tissue through an endoscope. The process includes controlling any bleeding that occurs during the treatment. |
16 | $533 | $2,647 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
15 | $102 | $380 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
14 | $102 | $638 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
12 | $19 | $84 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.3% high complexity
18.1% medium
81.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,182
Total received (2018-2024)
Avg $597/year across 7 years
Top 42% in TX for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
28
Companies
168
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$577
2023
$295
2022
$365
2021
$537
2020
$1,606
2019
$312
2018
$491
Payments by company (2024)
Sumitomo Pharma America, Inc.
$185
ABBVIE INC.
$170
Medtronic, Inc.
$116
Ferring Pharmaceuticals Inc.
$23
UROGEN PHARMA, INC.
$20
Merck Sharp & Dohme LLC
$20
Astellas Pharma US Inc
$19
Janssen Biotech, Inc.
$14
HealthTronics Stone Solutions, LLC
$11
Top 3 companies account for 81.6% of 2024 payments
All-time payments by company (2018-2024) ›
NeoTract Inc.
$1,403
Astellas Pharma US Inc
$823
Sumitomo Pharma America, Inc.
$340
Myovant Sciences Inc.
$255
ABBVIE INC.
$235
Janssen Biotech, Inc.
$195
Allergan Inc.
$178
Medtronic, Inc.
$116
Janssen Products, LP
$100
BOSTON SCIENTIFIC CORPORATION
$79
UROVANT SCIENCES INC
$64
Merck Sharp & Dohme LLC
$58
Novartis Pharmaceuticals Corporation
$49
Retrophin, Inc.
$34
Dendreon Pharmaceuticals LLC
$31
Ferring Pharmaceuticals Inc.
$23
Tolmar, Inc.
$21
UROGEN PHARMA, INC.
$20
Mission Pharmacal Company
$20
Myriad Genetic Laboratories, Inc.
$19
TOLMAR Pharmaceuticals, Inc.
$19
PFIZER INC.
$16
PROCEPT BioRobotics Corporation
$16
UroGen Pharma, Inc.
$15
Boston Scientific Corporation
$15
AbbVie, Inc.
$14
Endo Pharmaceuticals Inc.
$13
HealthTronics Stone Solutions, LLC
$11
Top 3 companies account for 61.4% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · AMS · AMS 700 CXR RTE KIT · AMS 700 CXR RTE Kit · AquaBeam Robotic System · BOTOX · BOTOX THERAPEUTIC · BRACANALYSIS CDX · Dornier MedTech · ELIGARD · ERLEADA · Erleada · GEMTESA · INTERSTIM · JELMYTO · KEYTRUDA · Lupron · MYRBETRIQ · Myrbetriq · ORGOVYX · PROVENGE · Uribel · UroLift · VESICARE · XIAFLEX · XTANDI · Xtandi · ZYTIGA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
11
County median income
$66,021
Nearest hospital to ZIP centroid (approximate)
CORPUS CHRISTI MEDICAL CENTER,THE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Naismith is a clinical cardiology specialist, with above-average Medicare volume (top 27% in TX), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Naismith experienced with manual urinalysis with microscopic examination?
Based on Medicare claims data, Dr. Naismith performed 1,235 manual urinalysis with microscopic examination services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Naismith receive payments from pharmaceutical companies?
Yes. Dr. Naismith received a total of $4,182 from 28 companies across 168 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Naismith's costs compare to other urology physicians in Corpus Christi?
Dr. Naismith's average Medicare payment per service is $47. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Naismith) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Corpus Christi
Browse urology physicians in Corpus Christi ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in TX
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in TX
Which TX urology physicians receive the most from drug and device companies.
By company
NeoTract Inc. Payments to Doctors
See all physicians who received payments from NeoTract Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Sumitomo Pharma America, Inc. Payments to Doctors
See all physicians who received payments from Sumitomo Pharma America, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology